- Home
- Publications
- Publication Search
- Publication Details
Title
Monoamine Reuptake Inhibitors in Parkinson’s Disease
Authors
Keywords
-
Journal
Parkinsons Disease
Volume 2015, Issue -, Pages 1-71
Publisher
Hindawi Limited
Online
2015-02-26
DOI
10.1155/2015/609428
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improving Response Inhibition in Parkinson’s Disease with Atomoxetine
- (2015) Zheng Ye et al. BIOLOGICAL PSYCHIATRY
- Selective serotonin reuptake inhibition modulates response inhibition in Parkinson’s disease
- (2014) Zheng Ye et al. BRAIN
- Effect of Deep Brain Stimulation on a Patient With Obstructive Sleep Apnea and Parkinson Disease: A Case Report
- (2014) Margarida Dias et al. CHEST
- UWA-121, a mixed dopamine and serotonin re-uptake inhibitor, enhances l-DOPA anti-parkinsonian action without worsening dyskinesia or psychosis-like behaviours in the MPTP-lesioned common marmoset
- (2014) Philippe Huot et al. NEUROPHARMACOLOGY
- Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease
- (2014) A.J.H. Moonen et al. PARKINSONISM & RELATED DISORDERS
- Reduction of Parkinsonism and Psychosis with Mirtazapine: A Case Report
- (2014) J. Godschalx-Dekker et al. PHARMACOPSYCHIATRY
- What is pharmacological ‘affinity’? Relevance to biased agonism and antagonism
- (2014) Terry Kenakin TRENDS IN PHARMACOLOGICAL SCIENCES
- Complete and Readily Reversible Blocking of Striatal DaTscan Binding by Methylphenidate
- (2013) Gang Cheng et al. CLINICAL NUCLEAR MEDICINE
- Behavioral characterization of the 6-hydroxidopamine model of Parkinson’s disease and pharmacological rescuing of non-motor deficits
- (2013) Miguel M Carvalho et al. Molecular Neurodegeneration
- Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: Possible serotonin syndrome
- (2013) Fanny Duval et al. MOVEMENT DISORDERS
- Tracking motor impairments in the progression of Huntington's disease
- (2013) Jeffery D. Long et al. MOVEMENT DISORDERS
- MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice
- (2013) Giulia Costa et al. MOVEMENT DISORDERS
- Magnetic resonance support vector machine discriminates between Parkinson disease and progressive supranuclear palsy
- (2013) Andrea Cherubini et al. MOVEMENT DISORDERS
- Rare sequence variants in ANO3 and GNAL in a primary torsion dystonia series and controls
- (2013) Michael Zech et al. MOVEMENT DISORDERS
- The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation
- (2013) Eunju Shin et al. NEUROBIOLOGY OF DISEASE
- Crack cocaine use due to dopamine agonist therapy in Parkinson disease
- (2013) J. H. Friedman et al. NEUROLOGY
- Motivational properties of D2 and D3 dopamine receptors agonists and cocaine, but not with D1 dopamine receptors agonist and l-dopa, in bilateral 6-OHDA-lesioned rat
- (2013) Yildiz Zengin-Toktas et al. NEUROPHARMACOLOGY
- Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian rats
- (2013) Melissa M. Conti et al. NEUROPHARMACOLOGY
- Methamphetamine Causes Degeneration of Dopamine Cell Bodies and Terminals of the Nigrostriatal Pathway Evidenced by Silver Staining
- (2013) Sara Ares-Santos et al. NEUROPSYCHOPHARMACOLOGY
- Prescription of drugs with potential adverse effects on cardiac conduction in Parkinson's disease
- (2013) Naveed M. Malek et al. PARKINSONISM & RELATED DISORDERS
- Illicit Stimulant Use Is Associated with Abnormal Substantia Nigra Morphology in Humans
- (2013) Gabrielle Todd et al. PLoS One
- Mirtazapine improves visual hallucinations in Parkinson's disease: a case report
- (2013) Kenji Tagai et al. Psychogeriatrics
- Prescription patterns of anticholinergic agents and their associated factors in Korean elderly patients with dementia
- (2013) Eun Kyung Lee et al. International Journal of Clinical Pharmacy
- The serotonergic system in motor and non-motor manifestations of Parkinson’s disease
- (2013) Philippe Huot et al. EXPERIMENTAL BRAIN RESEARCH
- Transient citalopram-induced auditory hallucinations in a patient with Parkinson’s disease and depression
- (2012) Anne P Wand AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls
- (2012) J.L. Riddle et al. BEHAVIOURAL BRAIN RESEARCH
- Impact of dopamine versus serotonin cell transplantation for the development of graft-induced dyskinesia in a rat Parkinson model
- (2012) Joanna García et al. BRAIN RESEARCH
- Positive allosteric modulation of α4β2 nAChR agonist induced behaviour
- (2012) F. Rode et al. BRAIN RESEARCH
- Serotonin transporter inhibition attenuatesl-DOPA-induced dyskinesia without compromisingl-DOPA efficacy in hemi-parkinsonian rats
- (2012) Christopher Bishop et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model
- (2012) Zacharias Kohl et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease
- (2012) Ubaldo Bonuccelli et al. EXPERT OPINION ON PHARMACOTHERAPY
- A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances l-DOPA benefit in parkinsonian primates
- (2012) Tom H. Johnston et al. FASEB JOURNAL
- A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson disease
- (2012) Tomoyuki Nagata et al. INTERNATIONAL PSYCHOGERIATRICS
- In Vivo Dopamine Transporter Imaging in a Unilateral 6-Hydroxydopamine Rat Model of Parkinson Disease Using 11C-Methylphenidate PET
- (2012) V. Sossi et al. JOURNAL OF NUCLEAR MEDICINE
- The role of the dopaminergic system in mood, motivation and cognition in Parkinson's disease: A double blind randomized placebo-controlled experimental challenge with pramipexole and methylphenidate
- (2012) Rosa L. Drijgers et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial
- (2012) Caroline Moreau et al. LANCET NEUROLOGY
- Sonographic abnormality of the substantia nigra in melanoma patients
- (2012) Jost-Julian Rumpf et al. MOVEMENT DISORDERS
- Tricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease
- (2012) Katrina L. Paumier et al. MOVEMENT DISORDERS
- Serotonin reuptake inhibitors for depression in PD
- (2012) Santiago Perez-Lloret et al. Nature Reviews Neurology
- Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease
- (2012) Eunju Shin et al. NEUROBIOLOGY OF DISEASE
- Effects of dopamine and serotonin antagonist injections into the striatopallidal complex of asymptomatic MPTP-treated monkeys
- (2012) Sara Neumane et al. NEUROBIOLOGY OF DISEASE
- Imaging DA release in a rat model of L-DOPA-induced dyskinesias: A longitudinal in vivo PET investigation of the antidyskinetic effect of MDMA
- (2012) Nadine Y. Lettfuss et al. NEUROIMAGE
- Methylphenidate for Gait and Attention Disorders in Advanced Parkinsonian Patients with Subthalamic Stimulation: A Multicentric Randomized, Double-Blind, Placebo-Controlled Study (S02.004)
- (2012) C. Moreau et al. NEUROLOGY
- A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
- (2012) I. H. Richard et al. NEUROLOGY
- Pharmacological modulation of amphetamine-induced dyskinesia in transplanted hemi-parkinsonian rats
- (2012) Gaynor A. Smith et al. NEUROPHARMACOLOGY
- The Monoamine Re-Uptake Inhibitor UWA-101 Improves Motor Fluctuations in the MPTP-Lesioned Common Marmoset
- (2012) Philippe Huot et al. PLoS One
- Impaired neurotransmission caused by overexpression of -synuclein in nigral dopamine neurons
- (2012) M. Lundblad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Serotonin Neuron Loss and Nonmotor Symptoms Continue in Parkinson's Patients Treated with Dopamine Grafts
- (2012) M. Politis et al. Science Translational Medicine
- Fluoxetine does not impair motor function in patients with Parkinson's disease: Correlation between mood and motor functions with plasma concentrations of fluoxetine/norfluoxetine
- (2012) Vladimir Kostic et al. Vojnosanitetski Pregled
- Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinsonʼs disease
- (2011) Krista McFarland et al. BEHAVIOURAL PHARMACOLOGY
- A major metabolite of bupropion reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets
- (2011) Matthew J. Hansard et al. BEHAVIOURAL PHARMACOLOGY
- Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease
- (2011) Ramachandiran Nandhagopal et al. BRAIN
- Enhanced Hyperthermia Induced by MDMA in Parkin Knockout Mice
- (2011) Y. Takamatsu et al. Current Neuropharmacology
- Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs
- (2011) Russell C. Callaghan et al. DRUG AND ALCOHOL DEPENDENCE
- Characterization of 3,4-Methylenedioxymethamphetamine (MDMA) Enantiomers In Vitro and in the MPTP-Lesioned Primate: R-MDMA Reduces Severity of Dyskinesia, Whereas S-MDMA Extends Duration of ON-Time
- (2011) P. Huot et al. JOURNAL OF NEUROSCIENCE
- Brain biochemistry in autopsied patients with essential tremor
- (2011) Holly A. Shill et al. MOVEMENT DISORDERS
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease
- (2011) Klaus Seppi et al. MOVEMENT DISORDERS
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
- (2011) Susan H. Fox et al. MOVEMENT DISORDERS
- DJ-1 and αSYN in LRRK2 CSF do not correlate with striatal dopaminergic function
- (2011) Min Shi et al. NEUROBIOLOGY OF AGING
- In vivo quantification of dopamine transporters in mice with unilateral 6-OHDA lesions using [11C]methylphenidate and PET
- (2011) Kristina Fischer et al. NEUROIMAGE
- Cerebrospinal fluid amyloid and tau in LRRK2 mutation carriers
- (2011) J. O. Aasly et al. NEUROLOGY
- Methylphenidate for gait impairment in Parkinson disease: A randomized clinical trial
- (2011) A. J. Espay et al. NEUROLOGY
- Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation
- (2011) Young C. Chung et al. NEUROPHARMACOLOGY
- The noradrenaline transporter as site of action for the anti-Parkinson drug amantadine
- (2011) Christian Sommerauer et al. NEUROPHARMACOLOGY
- Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease
- (2011) B.A. Morrow et al. NEUROSCIENCE
- Progesterone prevents depression-like behavior in a model of Parkinson's disease induced by 6-hydroxydopamine in male rats
- (2011) Sebastián Casas et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The serotonergic system in Parkinson's disease
- (2011) Philippe Huot et al. PROGRESS IN NEUROBIOLOGY
- Depression in Parkinson's Disease: Symptom Improvement and Residual Symptoms After Acute Pharmacologic Management
- (2010) Roseanne DeFronzo Dobkin et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials
- (2010) Petros Skapinakis et al. BMC Neurology
- Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation
- (2010) S. Thobois et al. BRAIN
- Impaired in vivo dopamine release in parkin knockout mice
- (2010) Genko Oyama et al. BRAIN RESEARCH
- Recent advances in PET imaging for evaluation of Parkinson’s disease
- (2010) Chrissa Sioka et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Locus coeruleus and dorsal raphe neuron activity and response to acute antidepressant administration in a rat model of Parkinson's disease
- (2010) Cristina Miguelez et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Bupropion in the treatment of depression in Parkinson's disease
- (2010) Maria Załuska et al. INTERNATIONAL PSYCHOGERIATRICS
- Venlafaxine-Associated Serotonin Syndrome Causing Severe Rhabdomyolysis and Acute Renal Failure in a Patient With Idiopathic Parkinson Disease
- (2010) Senaka Rajapakse et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Paroxetine Prevents Loss of Nigrostriatal Dopaminergic Neurons by Inhibiting Brain Inflammation and Oxidative Stress in an Experimental Model of Parkinson's Disease
- (2010) Y. C. Chung et al. JOURNAL OF IMMUNOLOGY
- The Impact of Antidepressant Treatment on Cognitive Functioning in Depressed Patients with Parkinson's Disease
- (2010) R. D. Dobkin et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Rhythmic pupillary oscillation in Creutzfeldt-Jakob disease associated with the Glu/Lys mutation of prion protein codon 200
- (2010) Kaori Nagasaka et al. MOVEMENT DISORDERS
- Bupropion abates dopamine agonist-mediated compulsive behaviors in Parkinson's disease
- (2010) Dario Benincasa et al. MOVEMENT DISORDERS
- Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders
- (2010) Russell C. Callaghan et al. MOVEMENT DISORDERS
- Parkinsonism in patients with a history of amphetamine exposure
- (2010) Chadwick W. Christine et al. MOVEMENT DISORDERS
- 5-HT2A receptor levels increase in MPTP-lesioned macaques treated chronically with L-DOPA
- (2010) Philippe Huot et al. NEUROBIOLOGY OF AGING
- Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
- (2010) D. Weintraub et al. NEUROLOGY
- Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease: Report of the Quality Standards Subcommittee of the American Academy of Neurology
- (2010) T. A. Zesiewicz et al. NEUROLOGY
- Persistent Nigrostriatal Dopaminergic Abnormalities in Ex-Users of MDMA (‘Ecstasy’): An 18F-Dopa PET Study
- (2010) Yen F Tai et al. NEUROPSYCHOPHARMACOLOGY
- Destruction of Dopaminergic Neurons in the Midbrain by 6-Hydroxydopamine Decreases Hippocampal Cell Proliferation in Rats: Reversal by Fluoxetine
- (2010) Katsuaki Suzuki et al. PLoS One
- Methamphetamine-Induced Dopamine-Independent Alterations in Striatal Gene Expression in the 6-Hydroxydopamine Hemiparkinsonian Rats
- (2010) Jean Lud Cadet et al. PLoS One
- MPTP- but Not Methamphetamine-Induced Parkinsonism Extends to Catecholamine Neurons in the Gut
- (2009) Gianfranco Natale et al. Annals of the New York Academy of Sciences
- Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
- (2009) ARCHIVES OF NEUROLOGY
- The use of an antagonist 5-HT2a/c for depression and motor function in Parkinson' disease
- (2009) Antonio Luiz dos Santos Werneck et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study
- (2009) R. Nandhagopal et al. BRAIN
- Amitriptyline is a TrkA and TrkB Receptor Agonist that Promotes TrkA/TrkB Heterodimerization and Has Potent Neurotrophic Activity
- (2009) Sung-Wuk Jang et al. CHEMISTRY & BIOLOGY
- Using Modafinil to Treat Fatigue in Parkinson Disease
- (2009) Jau-Shin Lou et al. CLINICAL NEUROPHARMACOLOGY
- Armodafinil
- (2009) Karly P. Garnock-Jones et al. CNS DRUGS
- Triple Reuptake Inhibitors: The Next Generation of Antidepressants
- (2009) David Marks et al. Current Neuropharmacology
- Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats
- (2009) E.L. Lane et al. EXPERIMENTAL NEUROLOGY
- Aripiprazole in l-dopa-induced dyskinesias: a one-year open-label pilot study
- (2009) Giuseppe Meco et al. JOURNAL OF NEURAL TRANSMISSION
- Modafinil for Parkinson’s disease fatigue
- (2009) Hilary L. Tyne et al. JOURNAL OF NEUROLOGY
- Management of non-motor complications in Parkinson’s disease
- (2009) Ken-ichi Fujimoto JOURNAL OF NEUROLOGY
- Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson’s disease and major depression
- (2009) Sven Pålhagen et al. JOURNAL OF NEUROLOGY
- HMPAO SPECT in Parkinson’s disease (PD) with major depression (MD) before and after antidepressant treatment
- (2009) Sven E. Pålhagen et al. JOURNAL OF NEUROLOGY
- Nonmotor Symptoms of Parkinson's Disease Revealed in an Animal Model with Reduced Monoamine Storage Capacity
- (2009) T. N. Taylor et al. JOURNAL OF NEUROSCIENCE
- Atomoxetine for freezing of gait in Parkinson disease
- (2009) Joseph Jankovic JOURNAL OF THE NEUROLOGICAL SCIENCES
- The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease
- (2009) Matthew Menza et al. MOVEMENT DISORDERS
- Mutant LRRK2 R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
- (2009) Yanping Li et al. NATURE NEUROSCIENCE
- Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease
- (2009) Emma Louise Lane et al. NEUROBIOLOGY OF DISEASE
- Sigma ligands, but not N-methyl-D-aspartate antagonists, reduce levodopa-induced dyskinesias
- (2009) Melanie A. Paquette et al. NEUROREPORT
- 5-HT antagonists NAN-190 and SB 269970 block α2-adrenoceptors in the guinea pig
- (2009) Jaime Pei Pei Foong et al. NEUROREPORT
- The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism
- (2009) Melanie A. Paquette et al. PSYCHOPHARMACOLOGY
- Depressive illness in Parkinson’s disease – indication of a more advanced and widespread neurodegenerative process?
- (2008) S. E. Pålhagen et al. ACTA NEUROLOGICA SCANDINAVICA
- Tesofensine (NS 2330), a Monoamine Reuptake Inhibitor, in Patients With Advanced Parkinson Disease and Motor Fluctuations
- (2008) Olivier Rascol ARCHIVES OF NEUROLOGY
- MPTP-induced Parkinsonism is associated with damage to Leydig cells and testosterone loss
- (2008) Riccardo Ruffoli et al. BRAIN RESEARCH
- Methylphenidate for the Treatment of Parkinson Disease and Other Neurological Disorders
- (2008) Eitan Auriel et al. CLINICAL NEUROPHARMACOLOGY
- Motor changes during sertraline treatment in depressed patients with Parkinson’s disease*
- (2008) J. Kulisevsky et al. EUROPEAN JOURNAL OF NEUROLOGY
- Therapeutic effects of Δ9-THC and modafinil in a marmoset Parkinson model
- (2008) Sanneke A.M. van Vliet et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Treatment of panic disorder with bupropion in a patient with Parkinson’s disease
- (2008) S. Gebhardt et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Striatal output markers do not alter in response to circling behaviour in 6-OHDA lesioned rats produced by acute or chronic administration of the monoamine uptake inhibitor BTS 74 398
- (2008) E. L. Lane et al. JOURNAL OF NEURAL TRANSMISSION
- Changes in psychomotor effects of L-dopa and methylphenidate after sustained dopaminergic therapy in Parkinson's disease
- (2008) A H Evans et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double-blind, randomized, placebo-controlled study
- (2008) David Devos et al. MOVEMENT DISORDERS
- The history of dopamine and levodopa in the treatment of Parkinson's disease
- (2008) Stanley Fahn MOVEMENT DISORDERS
- Movement disturbances in the differential diagnosis of Creutzfeldt-Jakob disease
- (2008) Jan Edler et al. MOVEMENT DISORDERS
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Microsubthalamotomy effect at day 3: Screening for determinants
- (2008) David Maltête et al. MOVEMENT DISORDERS
- Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: A pilot open-label study
- (2008) Laura Marsh et al. MOVEMENT DISORDERS
- Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease
- (2008) E.L. Lane et al. NEUROBIOLOGY OF DISEASE
- The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors
- (2008) K.E. Soderstrom et al. NEUROBIOLOGY OF DISEASE
- Sertraline in the treatment of depressive disorders in patients with Parkinson’s disease
- (2008) Silvia Marino et al. NEUROLOGICAL SCIENCES
- A controlled trial of antidepressants in patients with Parkinson disease and depression
- (2008) M. Menza et al. NEUROLOGY
- Invited Article: Functional imaging in Parkinson disease
- (2008) R. Nandhagopal et al. NEUROLOGY
- Antidepressants reverse the attenuation of the neurotrophic MEK/MAPK cascade in frontal cortex by elevated platform stress; reversal of effects on LTP is associated with GluA1 phosphorylation
- (2008) Hongshi Qi et al. NEUROPHARMACOLOGY
- Weight Loss Produced by Tesofensine in Patients With Parkinson's or Alzheimer's Disease
- (2008) Arne Astrup et al. Obesity
- Involvement of the serotonin system in l-dopa-induced dyskinesias
- (2008) Manolo Carta et al. PARKINSONISM & RELATED DISORDERS
- Differential expression of Fos and Zif268 in the nigrostriatal system after methamphetamine administration in a rat model of Parkinson's disease
- (2008) Yasushi Ishida et al. SYNAPSE
- Reuptake ofL-DOPA-derived extracellular DA in the striatum of a rodent model of Parkinson's disease via norepinephrine transporter
- (2008) Akira Arai et al. SYNAPSE
- Effects of Milnacipran and Paroxetine on Overactive Bladder due to Neurologic Diseases: A Urodynamic Assessment
- (2008) Ryuji Sakakibara et al. UROLOGIA INTERNATIONALIS
- Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy
- (2007) S.A.M. van Vlieta et al. BRAIN RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now